Pedulla Denise E 4
4 · NEOGENOMICS INC · Filed Mar 3, 2021
Insider Transaction Report
Form 4
Pedulla Denise E
General Counsel
Transactions
- Tax Payment
Common Stock
2021-03-02−216→ 56,298 total - Tax Payment
Common Stock
2021-03-01−212→ 56,514 total - Award
Common Stock
2021-03-02+4,345→ 60,643 total - Award
Stock Option (Right to Buy)
2021-03-02$53.17/sh+24,619$1,308,992→ 24,619 totalExercise: $53.17Exp: 2028-03-02→ Common Stock (24,619 underlying)
Holdings
- 17,496
Stock Option (Right to Buy)
Exercise: $19.60Exp: 2024-03-01→ Common Stock (17,496 underlying) - 18,757
Stock Option (Right to Buy)
Exercise: $28.33Exp: 2027-03-02→ Common Stock (18,757 underlying) - 48,334
Stock Option (Right to Buy)
Exercise: $8.03Exp: 2023-02-26→ Common Stock (48,334 underlying) - 25,000
Stock Option (Right to Buy)
Exercise: $7.52Exp: 2022-04-28→ Common Stock (25,000 underlying)
Footnotes (7)
- [F1]Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 1, 2021 vesting of restricted stock.
- [F2]Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2021 vesting of restricted stock.
- [F3]On April 28, 2017, Ms. Pedulla was granted 75,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
- [F4]On January 26, 2018, Ms. Pedulla was granted 72,500 stock options. These options vested ratably over the first three anniversary dates of the grant date.
- [F5]On March 1, 2019, Ms. Pedulla was granted 17,496 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F6]On March 2, 2020, Ms. Pedulla was granted 18,757 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F7]On March 2, 2021, Ms. Pedulla was granted 24,619 stock options. These options vest ratably over the first four anniversary dates of the grant date.